Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165058 · ClinicalTrials.gov registry record
Assessment of Colonic Epithelial Integrity With Mucosal Impedance
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT03165058 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT03165058 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
In this study, the investigators propose to use mucosal impedance (MI), a minimally invasive technology, to detect mucosal damage (i.e. barrier dysfunction) based on mucosal conductivity changes in the colonic epithelium.
Interventions
- DIAGNOSTIC_TEST mucosal impedance (MI) testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03165058
The ClinicalTrials.gov registry entry for NCT03165058 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mucosal impedance (MI) testing is the first listed.
NCT03165058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03165058 about?
NCT03165058 is a clinical study titled "Assessment of Colonic Epithelial Integrity With Mucosal Impedance". In this study, the investigators propose to use mucosal impedance (MI), a minimally invasive technology, to detect mucosal damage (i.e. barrier dysfunction) based on mucosal conductivity changes in the colonic epithelium.
What is the current status of trial NCT03165058?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2016-11. Estimated completion is 2019-05.
What interventions are being tested in trial NCT03165058?
The interventions under investigation include: mucosal impedance (MI) testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03165058?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.